Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine- pancreas gene as a liver tumor-specific promoter

Human Gene Therapy

Volumn 19, Issue 9, 2008, Pages 915-926

  Hervé, Julie ^a,b   Cunha, Antonio Sa ^a,b   Liu, Bingkai ^a,b   Valogne, Yannick ^a,b   Longuet, Michèle ^a,b,c   Boisgard, Raphaël ^a,d   Brégerie, Olivier ^a,b   Roux, Jérôme ^e   Guettier, Catherine ^a,b   Calès, Paul ^e   Tavitian, Bertrand ^a,d   Samuel, Didier ^a,b   Clerc, Jérôme ^f   Bréchot, Christian ^a,b   Faivre, Jamila ^a,b,g  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Mission des Affaires Européennes   (France)

^d DIF   (France)

^e UNIVERSITÉ D'ANGERS   (France)

^f UPRES EA 3859 ^*  (France)

^g HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; IODINE 131; PANCREATITIS ASSOCIATED PROTEIN; RADIOACTIVE IODINE; SODIUM IODIDE I 131; SODIUM IODIDE SYMPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG UPTAKE; HEPATIC ARTERY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; WESTERN BLOTTING; WISTAR RAT;

CYTOMEGALOVIRUS; RATTUS; RATTUS NORVEGICUS;

EID: 51849155380     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.153     Document Type: Article

References (49)

1. Avila, M.A., Berasain, C., Sangro, B., and Prieto, J. (2006). New therapies for hepatocellular carcinoma. Oncogene 25, 3866-3884.
2. Bal, C.S., Kumar, A., and Pant, G.S. (2004). Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: A randomized clinical trial in 509 patients. J. Clin. Endocrinol. Metab. 89, 1666-1673.
3. Benihoud, K., Salone, B., Esselin, S., Opolon, P., Poli, V., Di Giovine, M., Perricaudet, M., and Saggio, I. (2000). The role of IL-6 in the inflammatory and humoral response to adenoviral vectors. J. Gene Med. 2, 194-203.
4. Blechacz, B., Splinter, P.L., Greiner, S., Myers, R., Peng, K.W., Federspiel, M.J., Russell, S.J., and LaRusso, N.F. (2006). Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology 44, 1465-1477.
5. Boucher, E., Corbinais, S., Rolland, Y., Bourguet, P., Guyader, D., Boudjema, K., Meunier, B., and Raoul, J.L. (2003). Adjuvant intraarterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology 38, 1237-1241.
6. Cavard, C., Terris, B., Grimber, G., Christa, L., Audard, V., Radenenbussiere, B., Simon, M.T., Renard, C.A., Buendia, M.A., and Perret, C. (2006). Overexpression of regenerating islet-derived 1α and 3α genes in human primary liver tumors with β-catenin mutations. Oncogene 25, 599-608.
7. Chen, R.F., Li, Z.H., Pan, Q.H., Zhou, J.J., Tang, Q.B., Yu, F.Y., Zhou, Q.B., Wang, J., and Chen, J.S. (2007). In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter. Pancreatology 7, 505-513.
8. Christa, L., Carnot, F., Simon, M.T., Levavasseur, F., Stinnakre, M.G., Lasserre, C., Thepot, D., Clement, B., Devinoy, E., and Brechot, C. (1996). HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am. J. Physiol. 271, G993-G1002.
9. Christa, L., Simon, M.T., Brezault-Bonnet, C., Bonte, E., Carnot, F., Zylberberg, H., Franco, D., Capron, F., Roskams, T., and Brechot, C. (1999). Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. Am. J. Pathol. 155, 1525-1533.
10. Daniels, G.H., and Haber, D.A. (2000). Will radioiodine be useful in treatment of breast cancer? Nat. Med. 6, 859-860.
11. 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer. J. Nucl. Med. 45, 1549-1554.
12. Dingli, D., Peng, K.W., Harvey, M.E., Greipp, P.R., O'Connor, M.K., Cattaneo, R., Morris, J.C., and Russell, S.J. (2004). Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 103, 1641-1646.
13. Dusetti, N.J., Ortiz, E.M., Mallo, G.V., Dagorn, J.C., and Iovanna, J.L. (1995). Pancreatitis-associated protein I (PAP I), an acute phase protein induced by cytokines: Identification of two functional interleukin-6 response elements in the rat PAP I promoter region. J. Biol. Chem. 270, 22417-22421.
14. Dusetti, N.J., Vasseur, S., Ortiz, E.M., Romeo, H., Dagorn, J.C., Burrone, O., and Iovanna, J.L. (1997). The pancreatitis-associated protein I promoter allows targeting to the pancreas of a foreign gene, whose expression is up-regulated during pancreatic inflammation. J. Biol. Chem. 272, 5800-5804.
15. Dwyer, R.M., Bergert, E.R., O'Connor, M.K., Gendler, S.J., and Morris, J.C. (2006a). Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther. 13, 60-66.
16. Dwyer, R.M., Bergert, E.R., O'Connor, M.K., Gendler, S.J., and Morris, J.C. (2006b). Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum. Gene Ther. 17, 661-668.
17. Faivre, J., Clerc, J., Gerolami, R., Hervé, J., Longuet, M., Liu, B., Roux, J., Moal, F., Perricaudet, M., and Brechot, C. (2004). Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in Wistar rats. Cancer Res. 64, 8045-8051.
18. Gerolami, R., Cardoso, J., Bralet, M.P., Cuenod, C.A., Clement, O., Tran, P.L., and Brechot, C. (1998). Enhanced in vivo adenovirusmediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther. 5, 896-904.
19. Haberkorn, U., Kinscherf, R., Kissel, M., Kubler, W., Mahmut, M., Sieger, S., Eisenhut, M., Peschke, P., and Altmann, A. (2003). Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther. 10, 774-780.
20. He, T.C., Zhou, S., Da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95, 2509-2514.
21. Ido, A., Nakata, K., Kato, Y., Nakao, K., Murata, K., Fujita, M., Ishii, N., Tamaoki, T., Shiku, H., and Nagataki, S. (1995). Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res. 55, 3105-3109.
22. 2PB)-driven, prostatespecific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res. 63, 7840-7844.
23. Kramer, M.G., Barajas, M., Razquin, N., Berraondo, P., Rodrigo, M., Wu, C., Qian, C., Fortes, P., and Prieto, J. (2003). In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol. Ther. 7, 375-385.
24. Lau, W.Y., Leung, T.W., Ho, S.K., Chan, M., Machin, D., Lau, J., Chan, A.T., Yeo, W., Mok, T.S., Yu, S.C., Leung, N.W., and Johnson, P.J. (1999). Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. Lancet 353, 797-801.
25. Liu, B., Hervé, J., Bioulac-Sage, P., Valogne, Y., Roux, J., Yilmaz, F., Boisgard, R., Guettier, C., Cales, P., Tavitian, B., Samuel, D., Clerc, J., Brechot, C., and Faivre, J. (2007). Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. Gastroenterology 132, 1495-1503.
26. Lupoli, G.A., Fonderico, F., Colarusso, S., Panico, A., Cavallo, A., di Micco, L., Paglione, A., Costa, L., and Lupoli, G. (2005). Current management of differentiated thyroid carcinoma. Med. Sci. Monit. 11, RA368-RA373.
27. Magnon, C., Opolon, P., Ricard, M., Connault, E., Ardouin, P., Galaup, A., Métivier, D., Bidart, J.M., Germain, S., Perricaudet, M., and Schlumberger, M. (2007). Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1α-mediated tumor apoptotic switch. J. Clin. Invest. 117, 1844-1855.
28. Malka, D., Vasseur, S., Bodeker, H., Ortiz, E.M., Dusetti, N.J., Verrando, P., Dagorn, J.C., and Iovanna, J.L. (2000). Tumor necrosis factor α triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology 119, 816-828.
29. McCormick, F. (2001). Cancer gene therapy: Fringe or cutting edge? Nat. Rev. Cancer 1, 130-141.
30. Mitrofanova, E., Unfer, R., Vahanian, N., Kane, S., Carvour, M., and Link, C. (2005). Effective growth arrest of human colon cancer in mice, using rat sodium iodide symporter and radioiodine therapy. Hum. Gene Ther. 16, 1333-1337.
31. Montalto, G., Iovanna, J.L., Soresi, M., Dusetti, N., Carroccio, A., Barthelemy-Bialas, S., Cartabellotta, A., and Dagorn, J.C. (1998). Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: Comparison with α-fetoprotein. Oncology 55, 421-425.
32. Narushima, Y., Unno, M., Nakagawara, K., Mori, M., Miyashita, H., Suzuki, Y., Noguchi, N., Takasawa, S., Kumagai, T., Yonekura, H., and Okamoto, H. (1997). Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIIIα, RegIIIβ, RegIIIγ. Gene 185, 159-168.
33. Nishimune, H., Vasseur, S., Wiese, S., Birling, M.C., Holtmann, B., Sendtner, M., Iovanna, J.L., and Henderson, C.E. (2000). Reg-2 is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF survival pathway. Nat. Cell Biol. 2, 906-914.
34. Prieto, J., Qian, C., Hernandez-Alcoceba, R., Gonzalezaseguinolaza, G., Mazzolini, G., Sangro, B., and Kramer, M.G. (2004). Gene therapy of liver diseases. Expert Opin. Biol. Ther. 4, 1073-1091.
35. Rafaeloff, R., Pittenger, G.L., Barlow, S.W., Qin, X.F., Yan, B., Rosenberg, L., Duguid, W.P., and Vinik, A.I. (1997). Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J. Clin. Invest. 99, 2100-2109.
36. Robson, T., and Hirst, D.G. (2003). Transcriptional targeting in cancer gene therapy. J. Biomed. Biotechnol 2003, 110-137.
37. Sa Cunha, A., Bonte, E., Dubois, S., Chretien, Y., Eraiser, T., Degott, C., Brechot, C., and Tran, P.L. (2002). Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment. J. Hepatol. 37, 222-230.
38. Schipper, M.L., Weber, A., Behe, M., Goke, R., Joba, W., Schmidt, H., Bert, T., Simon, B., Arnold, R., Heufelder, A.E., and Behr, T.M. (2003). Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells. Cancer Res. 63, 1333-1338.
39. Scholz, I.V., Cengic, N., Baker, C.H., Harrington, K.J., Maletz, K., Bergert, E.R., Vile, R., Goke, B., Morris, J.C., and Spitzweg, C. (2005). Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther. 12, 272-280.
40. Spitzweg, C., Zhang, S., Bergert, E.R., Castro, M.R., McIver, B., Heufelder, A.E., Tindall, D.J., Young, C.Y., and Morris, J.C. (1999). Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 59, 2136-2141.
41. Spitzweg, C., Baker, C.H., Bergert, E.R., O'Connor, M.K., and Morris, J.C. (2007). Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum. Gene Ther. 18, 916-924.
42. Tabone, M., Vigano, L., Laudi, C., Ferrero, A., Pellerito, R., and Capussotti, L. (2005). Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: Which is the best treatment schedule? Hepatology 41, 1433; author reply 1433-1434.
43. Takayasu, K., Arii, S., Ikai, I., Omata, M., Okita, K., Ichida, T., Matsuyama, Y., Nakanuma, Y., Kojiro, M., Makuuchi, M., and Yamaoka, Y. (2006). Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131, 461-469.
44. Tazebay, U.H., Wapnir, I.L., Levy, O., Dohan, O., Zuckier, L.S., Zhao, Q.H., Deng, H.F., Amenta, P.S., Fineberg, S., Pestell, R.G., and Carrasco, N. (2000). The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med. 6, 871-878.
45. Vente, M.A., Hobbelink, M.G., van Het Schip, A.D., Zonnenberg, B.A., and Nijsen, J.F. (2007). Radionuclide liver cancer therapies: From concept to current clinical status. Anticancer Agents Med. Chem. 7, 441-459.
46. Wapnir, I.L., van de Rijn, M., Nowels, K., Amenta, P.S., Walton, K., Montgomery, K., Greco, R.S., Dohan, O., and Carrasco, N. (2003). Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J. Clin. Endocrinol. Metab. 88, 1880-1888.
47. Watanabe, K., Saito, A., and Tamaoki, T. (1987). Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene. J. Biol. Chem. 262, 4812-4818.
48. 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. J. Clin. Endocrinol. Metab. 92, 4451-4458.
49. Zenilman, M.E., Perfetti, R., Swinson, K., Magnuson, T., and Shuldiner, A.R. (1996). Pancreatic regeneration (reg) gene expression in a rat model of islet hyperplasia. Surgery 119, 576-584.